secwatch.observer — SEC 8-K summary
======================================

Issuer:     Evofem Biosciences, Inc. (EVFM)
CIK:        0001618835
Form:       8-K
Filed at:   2023-07-17T23:59:59+00:00
Accession:  0001493152-23-024717
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 3.03, 5.03, 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Evofem Biosciences dismisses Deloitte, appoints BPM as auditor; reduces stockholder quorum to one-third
--------------------------------------------------------------------------------

- Dismissed Deloitte & Touche as auditor effective July 11, 2023; no disagreements but prior reports included going-concern qualification.
- Appointed BPM LLP as new independent auditor, subject to stockholder ratification at 2023 Annual Meeting.
- Previously disclosed material weaknesses in internal control over financial reporting as of Dec 31, 2022.
- Amended bylaws to reduce quorum requirement for stockholder meetings from majority to one-third of outstanding shares.
- Removed requirement for Board consent to reschedule annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223024717/0001493152-23-024717-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1618835/000149315223024717/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-024717

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer